Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular Anomalies

Abstract

Objective. Matrix metalloproteinases (MMPs) and the angiogenic proteins basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) have been implicated in mechanisms of human cancer and metastasis. Assays were conducted on the urine of patients with vascular anomalies (tumors and malformations), relatively common and occasionally life-threatening disorders for which few therapies exist. We sought to determine whether these angiogenesis modulators are present in the urine and whether their expression is associated with the extent and clinical course of the vascular lesion.Methods. A total of 217 patients with vascular anomalies and 74 age-matched control subjects participated. Urinary MMP expression was determined by substrate gel electrophoresis. Urinary bFGF and VEGF levels were measured by enzyme-linked immunosorbent assay. Each patient was assigned to 1 of 2 categories (tumor or malformation) and 1 of 9 specific groups. Extent of the vascular lesion and activity were scored by a blinded clinician.Results. Urinary high molecular weight (hMW) MMPs and bFGF were significantly increased in patients with vascular tumors (53%) and vascular malformations (41%), compared with control subjects (22%). These percentages increased as a function of extent of the lesion and disease activity. hMW MMPs were increased in 4 groups: infantile hemangioma, other vascular neoplasms, lymphatic malformation and capillary-lymphaticovenous malformations, and extensive and unremitting capillary malformation and arteriovenous malformation. No significant differences among the groups were detected for low molecular weight MMPs or VEGF.Conclusions. Expression patterns of hMW MMPs and bFGF in the urine of patients with tumors and malformations are consistent with their different clinical behavior. These data represent the first evidence that MMPs are elevated in the urine of children with vascular anomalies. These data also suggest that the increased expression of urinary MMPs parallels the extent and activity of vascular anomalies in children. In addition to tumors, vascular malformations are angiogenesis dependent, suggesting that progression of a vascular malformation might be suppressed by angiogenic inhibitors, which would target bFGF and MMPs. Pediatrics 2005;116:38-45; vascular anomalies, matrix metalloproteinases, urinalysis.

Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes

“…These activities diminish with age and were less common in the age range of subjects investigated for this study (23). Furthermore, urinary MMP activities associated with physiological growth tend to be lower than the activities associated with pathological conditions of vascular remodeling and usually do not contain the high-molecular-weight complexes of NGAL/MMP-9 and MMP-9 multimers (22).…”

“…Even the large 125-kDa complex of MMP-9 and neutrophil gelatinaseassociated lipocalin (NGAL; also known as lipocalin-2), which protects MMP-9 from autodegradation, can be excreted in urine. MMP-2, MMP-9, and NGAL/MMP-9 are nearly absent in urine of unaffected adults but are excreted by individuals with various types of cancer or invasive vascular malformations and have been shown to predict both clinical stage and prognosis (10,11,23). …”

Percutaneous Doxycycline Treatment of Aneurysmal Bone Cysts With Low Recurrence Rate: A Preliminary Report

“…Doxycycline is an antibiotic that heals microcystic and macrocystic lymphatic malformations that are associated with elevated VEGF and MMPs [6,29,39,40]. In bone and soft tissue malignancy cell cultures, doxycycline demonstrates antitumoral properties with inhibition of MMP and angiogenesis [12,13,15], inhibition of osteoclastic function, and induction of osteoclastic apoptosis [12,13,15,19].…”

Angiogenesis in cutaneous disease: Part II

“…64 The overexpression of Akt1 in murine endothelial cells resulted in the development of vascular malformations characterized by dysfunctional endothelial cell remodeling. 85 Marler et al 86 showed increased levels of urine MMPs in patients with both vascular tumors and vascular malformations compared to control subjects. An increased expression of urinary MMPs correlated with the extent and activity of the vascular anomalies and may offer a method for monitoring treatment efficacy in patients with vascular malformations.…”